Skip to content

Safety of Lactobacillus Fermentum in Newborn Infants

Study of Tolerance of an Infant Formula Supplemented With Lactobacillus Fermentum CECT5716

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01346644
Enrollment
137
Registered
2011-05-03
Start date
2009-02-28
Completion date
Unknown
Last updated
2013-05-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Tolerance

Keywords

Probiotic, infant nutrition, safety, infections

Brief summary

In the last years manipulation of intestinal microbiota with probiotics has gained an increasing interest, specially in infant nutrition since recent studies has demonstrated the presence of probiotics in human milk. However, there are few studies studying the effects of probiotics in newborns. The objective of the present study is to analyze safety and tolerance of the probiotic Lactobacillus fermentum CECT5716 isolated from human milk.

Interventions

OTHERInfant formula

Powder infant formula

Sponsors

Puleva Biotech
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
ALL
Age
21 Days to 30 Days

Inclusion criteria

* Healthy 1 month infants exclusively formula-fed

Exclusion criteria

* gastrointestinal disorders (history of chronic diarrhoea or constipation, gastroesophageal reflux) * gastrointestinal surgery * cow's milk protein allergy * metabolic disorders (diabetes, lactose intolerance) * immune deficiency * antibiotic prescription 1-week prior to inclusion and previous use of formula containing prebiotics or probiotics

Design outcomes

Primary

MeasureTime frame
average weight gain4 months

Secondary

MeasureTime frameDescription
growth and health of infants2,4,6,12 and 36 months of lifeaverage weight, length of infants. Incidence of infections. Incidence of allergic diseases

Countries

Spain

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026